Loading company…
Tianjin Century Kangtai develops ophthalmic medical devices using collagen-based biomaterials.
Established in 2008 and based in Tianjin, China, Tianjin Century Kangtai develops eye health products, including intraocular lenses and collagen sponge biomaterials. Its products include foldable IOLs and ocular fixation rings. In September 2023, it closed Series B funding led by SDIC Unity Capital, with Dongguan Songshan Lake Science City Development Group, Efung Capital, Jinju Capital, and Xiaochi Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in